Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730510 | SCV000858252 | pathogenic | not provided | 2017-12-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535156 | SCV002978103 | pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2023-02-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser471Cysfs*30) in the MCCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC2 are known to be pathogenic (PMID: 11181649, 22642865). This variant is present in population databases (rs780304038, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with MCCC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 595072). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV002535156 | SCV004194389 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2022-11-06 | criteria provided, single submitter | clinical testing |